Genome BC Invests C$750K in Startup Microbiome Insights

Dec 06, 2017

|

NEW YORK (GenomeWeb) – Genome BC said today that it is investing C$750,000 ($586,000) in Microbiome Insights (MBI), a Vancouver-based microbiome testing company.

MBI provides next-generation sequencing-based analytical testing and consulting services to microbiome researchers in academia and industry.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Menu

Genome BC Invests C$750K in Startup Microbiome Insights

To read the full story....

Breaking News

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Agendia Settles Allegations of Medicare Fraud for $8.25M

Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

Translation of Dog Years Into Human Years Updated With Epigenetic Analysis

Type 2 Diabetes Associated With Altered Daily Gut Microbe Oscillations

In Brief This Week: Genomics England, Centogene, Cergentis, and More

The Scan

Working Out the Effect

Increased Genetic Privacy in Florida

Attention-Grabbing in Two Ways

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

What's Popular?

Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index

Centogene Gets Emergency Use Authorization for PCR-Based Coronavirus Test

FDA Issues Warning Letter to Luminex

Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test

Sponsorships